Nicole Perry - Vice President - Accounting at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (Right to Buy)	6.16K	$408K	$66.30	Aug 2, 2021	Direct	Common Stock
Common Stock	4.85K	$309K	$63.69	Aug 2, 2021	Direct

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.